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ABSTRACT 
BACKGROUND: Trachoma is a leading cause of avoidable blindness. Currently, 
trachoma is endemic in 57 countries, infects approximately 84 million people globally, 
and continues to threaten over 10 % of the world’s population with the risk of blindness.  
Caused by the bacteria Chlamydia trachomatis, blindness due to trachoma is caused by 
repeated eye infection resulting in the inflammation of the upper eyelid eventually 
leading the upper lid to pull inward scratching and tearing the cornea causing it to 
become opaque resulting in loss of vision.  The World Health Organization recommends 
eliminating trachoma as a public health problem using the SAFE strategy:  Surgery, 
Antibiotic, Face washing and Environmental control. 
 
OBJECTIVES:  This review examined the benefits of the added value of water, 
sanitation, and hygiene education interventions on preventive mass drug administration 
for trachoma. 
 
METHODS: Trials were identified from MEDLINE, PubMed, and LISTA EBSCO 
databases using a series of search terms. No restrictions were put on study date, location, 
design, or language of publication.  The abstracts were examined from each of the 
searches, and any abstract describing risk factors, survey results of mass drug 
administration (MDA), or providing a general overview of trachoma were automatically 
discarded.  Full text of papers including the combined use of key words including SAFE, 
WASH, intervention, impact, added value, MDA, azithromycin/ Zithromax® were 
obtained for review. Twelve full texts articles were retrieved all relevant information 
were placed in a standardized data extraction form.   
 
MAIN RESULTS:  Three studies met the complete criteria for inclusion. All studies 
found a significant change in reduction of active trachoma prevalence. One study focused 
on the added benefit of antibiotic and environmental components on hygiene education 
delivered by radio. Another trial compared two villages; the control community 
performed MDA and the surgery while the intervention village added the F and E 
components.  The final study as well focused the added benefit of ‘F’ and ‘E’ on ‘A’.   
Two of the three studies found this reduction was from the added benefit of face washing 
‘F’ and environmental control ‘E’ to antibiotic use.  
 
CONCLUSIONS:  In order to eliminate blinding trachoma as a public health problem, 
recurrence of the active form of the disease must be interrupted before repeated scarring 
leads to trichiasis.  The antibiotic component of the SAFE strategy is a quick fix to the 
immediate problem.  The ‘F’ and ‘E’ components are the more sustainable interventions, 
yet little research has been done on the actual amount of added value the individual 
‘A’‘F’&’E’ components have to one another.  After thorough review of the articles, 
articles were found which documented the ‘F’ and ‘E’ components provide significant 
value to the overall decrease of prevalence of active.  However, the limited results of the 
search suggest more research can better elucidate the ability of the ‘F’ and ‘E’ 
components to reduce trachoma prevalence and ultimately impact blinding.  
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CHAPTER I 
INTRODUCTION 
1.1 Overview 
Trachoma 
Caused by the bacteria Chlamydia trachomatis, trachoma is the world’s leading cause of 
preventable blindness, debilitating some of the world’s most marginalized peoples (2006).   
Currently, trachoma is endemic in 57 countries, infects approximately 84 million people 
globally, and continues to threaten over 10% of the world’s population with the risk of blindness 
(Mariotti, Pascolini et al. 2009; ITI 2010).  Blindness due to trachoma is caused by repeated eye 
infection resulting in the inflammation of the upper eyelid eventually leading to scarring.  
Scarring, over time, shortens the upper lid causing the eye lashes to pull inward scratching and 
tearing the cornea and causing it to become opaque resulting in loss of vision (Pruss and Mariotti 
2000; Solomon and Mabey 2007).  To date, eight million people are blind or visually impaired 
due to the reoccurrence of trachoma infection (ITI 2010). 
 
Transmission 
After over 50 years of studies, consensus on the routes of trachoma transmission remains 
unchanged (Emerson, Cairncross et al. 2000). T The routes of transmission, all of which are 
hygiene-related, include indirect infection by the fly vector, Musca sorben, which breeds in 
nearby exposed feces (Mecaskey, Knirsch et al. 2003).  The flies spread the disease person to 
person by landing on dirty faces of infected individuals and transporting the infection to others 
(Pruss-Ustun, Bonjour et al. 2008).  Direct person-to-person contact, as well as indirect contact 
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via clothing, towels, handkerchiefs, bed sheets, and pillows causes the trachoma bacteria to 
spread among families, schools, and other groups (TCC 2010).  
 
SAFE Strategy  
Surgery (S), Antibiotic (A), Facial Cleanliness (F), Environmental Control (E) 
The World Health Organization’s (WHO) strategy to eliminate all avoidable blindness by the 
year 2020 is called VISION 2020: Right to Sight.  Trachoma is specifically targeted in this 
initiative through an alliance of partners working with WHO called the Global Elimination of 
Trachoma as a Cause of Blindness by the Year 2020 (GET 2020) (Pruss and Mariotti 2000).  
Elimination of trachoma-related blindness can be accomplished through the implementation of 
the complete SAFE strategy.  The SAFE strategy includes the following: prevention of blindness 
by treating end stage trachoma through surgery; reduction of the reservoir of infection by 
distributing antibiotics such as azithromycin; and removal of risk factors that encourage 
transmission of infection through facial cleanliness and environmental changes (Mabey, 
Solomon et al. 2003). 
 
Risk factors for trachoma are associated with lack of access to water, sanitation and hygiene 
(WASH) (Fewtrell 2004).  Poverty creates a major barrier to gaining access to clean water, 
perpetuating the link between trachoma, lack of water, sanitation, and hygiene education, and 
economic development (UNDP 2006).  According to the WHO, “the availability of clean water 
is a prerequisite to the sustainable growth and development of communities around the world” 
(Choffnes 2009).  The conditions of poverty and inequality which perpetuate the prevalence of 
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trachoma and unsafe water and sanitation continue claiming lives, destroying livelihoods, and 
compromising prospects for economic growth (UNDP 2006). 
 
WASH: Water, Sanitation and Hygiene 
Globally approximately 10 % of the global burden of disease and 6.3 % of all deaths are due to 
unsafe water, inadequate sanitation, and insufficient hygiene (Pruss-Ustun, Bonjour et al. 2008).  
Over 1.1 billion people still defecate in the open and approximately 884 million people still do 
not get their drinking water from improved sources (UNICEF 2010).  WASH interventions are 
programs specific to water, sanitation, and hygiene education and work to reduce the global 
burden of water and hygiene related diseases.  WASH interventions, synonymous with the ‘F’ 
and ‘E’ components of SAFE, can be categorized into three groups: 
  
1. Water supply, sanitation and hygiene  
2. Water resources managements 
3. Safety and environments 
 
Trachoma is directly impacted by water supply, sanitation, and hygiene (Choffnes 2009).  Water 
supply interventions at a public or household level include new or improved water supply source 
and distribution methods.  The installation of hand pumps and household connections are often 
recognized as examples of water supply interventions.  Sanitation interventions, such as 
construction of latrines, provide means of excreta disposal. Finally, hygiene interventions target 
specific behavior change, such as face washing, through hygiene and health education (Prüss-
Üstün). 
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1.2 Purpose of Study  
The ‘A’, ‘F’, and ‘E’ components of the SAFE strategy focus on the reduction of disease 
transmission and the impact on trachoma prevalence.  Because active trachoma clusters in 
households or social groups, infection control  should consist of community-based efforts to 
interrupt transmission (West 2003).  This type of control is evident through annual mass drug 
administration (MDA) of azithromycin which is considered a safe, simple, and effective way to 
treat trachoma (Bailey and Lietman 2001).  Through annual MDA, the ‘A’ component of SAFE 
becomes a preventive intervention as well as a treatment based intervention (WHO 2006).    
When regular treatment with antibiotics is complemented with the ‘F’ and ‘E’ components via 
improvements in water, sanitation, and hygiene education, transmission of trachoma can 
decrease to the point of elimination as a public health concern (Ngondi, Onsarigo et al. 2006). 
 
The purpose of this review was to address the need for collaboration between organizations 
focused on different aspects of the SAFE strategy, i.e. WASH organizations and pharmaceutical 
donation programs.  In order to reduce the burden of trachoma, and meet the targeted goal of 
elimination as a public health problem by the year 2020, there is a critical need to integrate the 
multifaceted approaches of trachoma control and prevention (Emerson, Lindsay et al. 2004).  
The review examined current evidence-based literature in an attempt to determine the added 
value of water, sanitation, and hygiene interventions on preventive chemotherapy programs 
described as MDA of azithromycin or Zithromax® donated by Pfizer.  Change of prevalence 
within the context of the SAFE strategy is reviewed, revealing gaps in research and identifying 
the need for future studies.  
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CHAPTER II 
REVIEW OF THE LITERATURE 
 
2.1 History 
The Chlamydia trachomatis bacterium has been around since the Jurassic period (Mathew, 
Turner et al. 2009).  However, it did not manifest into what is known today as blinding trachoma 
until humans began living in clusters, creating optimal places for bacteria to spread from 
crowding and poor hygiene (Taylor 2008).  Reports of this disease date as far back as the ancient 
Egyptians, Chinese, and Greeks (Taylor 2008; Taylor 2009). 
 
Trachoma’s effect on ancient Egyptians was evidenced through artifacts found in tombs 
including epilation devices for pulling out lashes and depictions of treatments for eye diseases 
written on papyrus called the Ebers’ papyrus (West 2004).  In ancient China mention of surgery, 
for what Hippocrates (460-377 BC) termed ‘trichiosis’ (in-turned eye lashes), dates back to the 
27th century BC (Taylor 2008).  It was not until the Greek physician Galen (126-216 AD) that 
trachoma was defined as hardness and roughness of the inner surface of the eye.  His description 
of trachoma’s various forms are similar to the ones still used today (Trompoukis and Kourkoutas 
2007).  The association between repeated trachoma infection leading to blinding trichiasis was 
not made until the 11th century, by the Arab physician Ibn ‘Isa (Mecaskey, Knirsch et al. 2003). 
 
Europe first noted trachoma after the Napoleonic wars (Hu, Harding-Esch et al. 2010).  
Trachoma initiated in the crowded barracks of British and French soldiers in Egypt, and 
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continued to spread to the general population once the troops returned home (Kumaresan 2005).  
From Europe the disease spread to the United States by immigrants (Mecaskey, Knirsch et al. 
2003).  Regulations were established and points of entry, including Ellis Island, were screened 
for signs of trachoma.  If signs of the trachoma were detected the individual was offered 
treatment and then returned to their native land (Yew 1980). 
 
The infection has disappeared from most developed countries (Taylor 1990).  Places like the 
United States, Japan, the United Kingdom, and USSR were all endemic for trachoma at one point 
in their history but after years of treatment and development, blinding trachoma was eliminated 
(Taylor 2008).  The difference between these countries and the countries where trachoma is still 
endemic is the amount of effort and money available for elimination programs.  If all associated 
factors important to transmission of trachoma are not addressed, then a sustainable program 
cannot be created and the disease is likely to recur (Taylor 2008). 
 
2.2 Clinical diagnosis 
Throughout the years various grading systems for trachoma have been proposed (Hu, Harding-
Esch et al. 2010).   These forms have continued to follow the same form as Galen’s initial 
observations (Trompoukis and Kourkoutas 2007).  Most recently, WHO created a simplified 
trachoma grading scale to utilize non-specialized personnel and to report signs of trachoma 
simply and consistently.  This system is now the most commonly used by program managers 
globally (Solomon and Mabey 2007).  The WHO simplified system divides trachoma into five 
signs:  
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1. Trachomatous inflammation (TF) - (follicles): The presence of five or more   follicles, 
at least 0.5mm in size, on the 'flat' surface of the upper tarsal conjunctiva. 
 
2. Trachomatous inflammation (TI) - (intense): inflammatory thickening of the upper 
tarsal conjunctiva with more than half of the normal deep tarsal vessels obscured. 
 
3. Trachomatous scarring (TS): scarring of the tarsal conjunctiva (fibrosis). 
 
4. Trachomatous trichiasis (TT): at least one eyelash rubbing on the eyeball or evidence 
of eyelash removal. 
 
5. Corneal Opacity (CO): where at least part of the pupil is blurred or obscured.  
(WHO trachoma grading card) 
 
TF and TI are described as active trachoma and TS, TT, and CO are considered cicatricial forms 
of trachoma (Thylefors, Dawson et al. 1987; Landers, Kleinschmidt et al. 2005) .  Individuals, 
usually children, are infected with TF or TI and may be asymptomatic and therefore do not seek 
treatment (Kuper, Solomon et al. 2003) (Mabey, Bailey et al. 1991).  The lack of immediate care 
can lead to repeated infection and increase the severity of symptoms by developing scars on the 
upper eyelid which shift the diagnosis from active to cicatricial trachoma (Munoz and West 
1997).  
 
2.3 SAFE strategy 
As mentioned previously, the SAFE strategy is a multifaceted methodical initiative attempting to 
stop all levels of disease transmission and eliminate its reoccurrence (Emerson, Lindsay et al. 
2004).  The components of SAFE are implemented as both long and short term interventions of 
trachoma (West 2003).  The prevalence of TF in children aged 1–9 years is the key index for 
determining whether an area needs intervention with the A, F and E components of SAFE. The 
prevalence of TT determines the probable need for surgical services (ITI 2010). 
8 
 
 
Surgery (S) 
The final stage of the Chlamydia trachomatis infection, trichiasis (TT), poses the greatest risk for 
corneal ulcers leading to blindness (Bailey and Lietman 2001).  As stated previously, corneal 
opacity and blindness are due to the continued occurrence of active trachoma as a child and can 
be stopped with surgery (West 2004).  Surgery to correct in-turned lids is relatively short in time 
and can be performed by a general physician or trained ophthalmic nurses (ITI 2010).  There are 
different types of TT surgery, all of which focus on turning the lid outward by 90 or more 
degrees (Schachter and Dawson 2002).  According to Baltussen, Sylla et al. 2005, if 80% of 
coverage is obtained through trichiasis surgery 11 million disability adjusted life years (DALYs) 
per year would be averted globally (Baltussen, Sylla et al. 2005). 
 
The impact of surgery is measured in terms of recurrence of trichiasis after surgery, including the 
position of one single lash touching the cornea (Kuper, Solomon et al. 2003).  Recurrence may 
be considered to some degree inevitable due to the pathology of trachoma to continue scarring 
and the predisposition of a torn cornea to bacterial infection (Mathew, Turner et al. 2009). 
Several factors contribute to recurrent trichiasis such as the type of procedure used, the surgeon’s 
experience, and infection status (Rajak, Makalo et al. 2010).  However, long-term success rates 
for the procedure are approximately 80% (ITI 2010). 
 
Another important factor affecting the impact of trichiasis surgery is the lack of accessibility to 
surgery (Hu, Harding-Esch et al. 2010).  If the procedure was readily available at the community 
level, people with trichiasis would be more motivated to come forward for surgical correction 
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(Mecaskey, Knirsch et al. 2003). To help increase up-take of surgical services by patients, 
interventions such as mobile surgical camps provide communities access to surgery with little or 
no cost to the patient (Mabey, Solomon et al. 2003). 
 
Antibiotic (A) 
The ‘A’ component of the SAFE strategy is the current method of trachoma control for the active 
disease, TF or TI (ITI 2010).  Active infection can be asymptomatic, influencing diagnosis and 
spot treatment (Kuper, Solomon et al. 2003) (Schachter and Dawson 2002).  The WHO 
recommends mass antibiotic treatment of the entire district population annually for three years if 
active trachoma prevalence is above 10%   (Hu, Harding-Esch et al. 2010).  Due to the inclusive 
nature of MDA programs, they are successful in reducing the prevalence of infection below a 
certain threshold which slows trachoma transmission to the point of no longer being a public 
health problem.  The disease becomes more manageable by other factors making re-emergence 
of diseases as a public-health problem unlikely (Smits 2009). 
 
Before Pfizer began donating Zithromax®, an  ingestible antibiotic, for trachoma control, 
tetracycline eye ointment was used as the antibiotic component of the SAFE strategy (ITI 2010).  
Tetracycline compliance, and therefore effectiveness, was affected by its tedious application 
process, twice a day for six weeks.  Since the donation from Pfizer began in 1999, population 
coverage in the ‘A’ component reached more than 90% coverage at the WHO suggested district 
level (Kumaresan 2005).  Additionally, azithromycin treatments are easily administered by 
community control programs through height-based dosing, and are considered by some to be the 
closest to the perfect antibacterial for MDA (Bailey and Lietman 2001) (Mathew, Turner et al. 
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2009).  If azithromycin coverage achieves a 95% level, more than 4 million DALYs would be 
averted each year globally (Baltussen, Sylla et al. 2005). 
 
A Cochrane review of antibiotics administration for reduction of trachoma prevalence was 
published in 2005.  It concluded that antibiotic treatment for active trachoma seemed to reduce 
the relative risk of clinical disease and infection 3-12 months after treatment, however the results 
were inconclusive as to whether antibiotic treatment for active trachoma was effective (Mabey, 
Fraser-Hurt et al. 2005).  Since the review, other cohort studies have been published with the 
same outcomes, in absence of the SAFE strategy,  it was concluded that trachoma would return 
over a 24-month period (Taylor 2008). 
 
Face washing and Environmental control (F & E) 
The ‘F’ and ‘E’ components of the SAFE strategy are related and sometimes presented together. 
They are interventions which target water supply, sanitation, and hygiene education (Mecaskey, 
Knirsch et al. 2003).  As discussed previously, trachoma is a disease prevalent in low 
socioeconomic countries and transmission of disease is due to lack of hygiene (Emerson, 
Cairncross et al. 2000).  Unclean faces is a transmission route for the trachoma bacteria via direct 
person to person through ocular and nasal discharge and face washing decreases this potential 
source for the infection (Kuper, Solomon et al. 2003).  It is difficult to achieve a behavioral 
change in face washing because of prolonged local involvement to implement, and the lack of 
appropriate monitoring measures (Taylor 2008) (King, Ngondi et al. 2010).  However, West, 
Munoz et al. 1995 demonstrated the sustainability and long term benefits in the reduction of 
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prevalence severe trachoma and an increase in consistent face washing once it is implemented 
(West, Munoz et al. 1995) (Mathew, Turner et al. 2009).  
 
Economic stability affects poor living conditions increasing the need for environmental 
interventions in trachoma control (Mathew, Turner et al. 2009).   Trials suggest that interventions 
of the ‘E’ component including use of latrines, insecticide spray, and health education can reduce 
transmission of active trachoma (Pruss and Mariotti 2000).  Due to the extended time needed to 
accurately interpret the effect the ‘E’ component interventions, additional studies are needed to 
understand the sustainability  of these interventions (Rabiu, Alhassan et al. 2007).  The scope of 
these components is so comprehensive that collaboration between country ministries’ of 
sanitation, education, and health is needed (ITI 2010).  Figure 1 represents trachoma The 
interventions include specific means of hygiene education which that communicate trachoma 
risk factors and prevention.  Ohter interventions include water supply via wells, hand pumps, and 
storage, and sanitation through the use of latrines. 
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Figure 1: Diagram of transmission pathways and intervention 
 
2.4 Impact of full SAFE 
In order to receive Pfizer donated Zithromax® from the International Trachoma Initiative (ITI) a 
country is required to fill out an application including baseline prevalence survey results to 
illustrate endemicity.  It is also recommended, in endemic areas, an impact survey be done three 
years after distribution (ITI 2010).  Because of this requirement, several cross-sectional impact 
studies are now available describing the specific effects of antibiotics on prevalence of trachoma.  
Additionally, some researchers assessed the impact of the full SAFE strategy on prevalence of 
trachoma.  In Roba et al. 2010, a study which included four regions across Ethiopia, the 
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prevalence of active trachoma (TF) was reduced from 36.7% to 18.4%, a significant 47% change 
in reduction (Roba, Wondimu et al. 2010).   
 
A similar study looking at the impact of the ‘A’, ‘F’, and ‘E’ components was done by Ngondi et 
al. 2006.  In this study the full SAFE strategy was being carried out in 4 different sites all having 
different amounts of control, but at different rates of uptake.  The sites with the highest coverage 
of ‘A’, ‘F’, and ‘E’ interventions had the largest reduction of active trachoma (Ngondi, Onsarigo 
et al. 2006).  Logistically, it is impractical to achieve sustainable results by individual 
interventions such as surgery and antibiotic therapy alone, the addition of the ‘F’ and ‘E’ 
components are needed to reduce transmission pathways (Emerson, Cairncross et al. 2000).   
 
The prior studies confirmed that a comprehensive effort is needed to maximize results in 
decreasing the prevalence of active trachoma.  In the following research, a systematic review was 
conducted to establish the added value of WASH interventions, the components ‘F’ and ‘E’ of 
the SAFE strategy, on the mass distribution of azithromycin the ‘A’ component.  Knowing the 
added value of specific components will help advocate for further integration between trachoma 
programs and WASH organizations. This collaboration can occur through the selection of 
mutually beneficial intervention sites as well as identification of the most effective WASH 
indicators producing an impact on trachoma. 
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Chapter III  
METHODOLOGY 
 
3.1 CRITERIA FOR CONSIDERING STUDIES FOR THIS REVIEW 
Initial Selection Criteria 
Eligible study designs included peer-reviewed studies evaluating the impact of WASH 
interventions on the antibiotic component of the SAFE strategy.  All articles included in the 
review were required to report trachoma prevalence data pre- and post-program implementation.  
Any studies focused specifically on the outcomes of WASH interventions as an added value to 
Mass Drug Administration (MDA) of azithromycin treatments were included.  Due to limitations 
of monitoring and lack of compliance with the use of tetracycline, studies distributing 
tetracycline and not azithromycin to people with active trachoma were excluded.  All impact 
studies, totaling four from the keyword search, providing a complete assessment of the SAFE 
strategy and its impact on trachoma prevalence, rather than the added benefits of the 
interventions to one another were additionally excluded.  Other excluded articles were those that 
focused on analyzing risk-factors for trachoma and providing descriptions of trachoma and 
SAFE strategy through literature-based review. 
 
3.2 Types of outcome measures 
Primary Outcome 
The primary outcome measure for this review was prevalence of active trachoma measured as 
the number of participants with Trachoma Follicular (TF) and/ or Trachoma Inflammation (TI) 
15 
 
pre-and post-intervention.  Active trachoma was identified by the WHO trachoma grading scale 
and/ or diagnostic swab testing. 
 
Secondary Outcome 
Secondary outcomes included changes in knowledge, attitudes, and practice specific to the risk 
factors associated with prevention of trachoma through antibiotics, face washing, and 
environmental control. 
 
3.3 Search strategy 
Electronic searches 
The PubMed database searches were made with key word searches pairing aspects of water, 
sanitation and hygiene education against trachoma and either preventive chemotherapy, mass 
chemotherapy, or antibiotic.  No restrictions were put on study date, location, design or language 
of publication.  Similar searches were conducted using LISTA EBSCO, and MEDLINE which 
yielded no additional papers relating to WASH interventions on preventive chemotherapy 
interventions.  A complete list of the key word search and results for each search are included 
below: 
 
Table 1: Keyword search by name and results 
 
SEARCH NAME SEARCH 
RESULTS 
Antibiotic and Water and Sanitation and Hygiene Education 11 
Azithromycin and Water and Sanitation and Hygiene Education and trachoma 2 
Hygiene Education and Antibiotic and trachoma 20 
16 
 
Hygiene Education and Preventive Chemotherapy and trachoma 2 
Hygiene Education and Mass Chemotherapy and trachoma 5 
Mass Chemotherapy and Water and Sanitation and Hygiene Education 6 
Preventive Chemotherapy and Water and Sanitation and Hygiene Education 2 
SAFE strategy and trachoma and intervention 27 
Sanitation and Antibiotic and trachoma 17 
Sanitation and Mass Chemotherapy and trachoma 5 
Trachoma and Water and Sanitation and Hygiene Education 18 
Water and Sanitation and Hygiene Education and Antibiotic and Trachoma 5 
Water and Sanitation and Hygiene Education and Mass Chemotherapy and 
Trachoma 1 
Water and Mass Chemotherapy and trachoma 5 
Water and Antibiotic and trachoma 24 
  
 
TOTAL NUMBER OF ARTICLES FROM SEARCH: 150 
 
TOTAL NUMBER OF NON-REPEATED SEARCHES: 81 
 
TOTAL NUMBER RELEVANT TO REVIEW  (in non-repeated searches) 3 
 
 
3.4 Data collection and analysis 
Selection of studies 
One author screened titles and abstracts found in the electronic databases.  Any confusion about 
studies was resolved by an external source.  The abstracts were examined from each of the 
searches, any abstract describing risk factors, survey results of MDA specifically, or providing a 
general overview of trachoma were automatically discarded.  Full copies of papers including the 
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combined use of key words including SAFE, WASH, intervention, impact, added value, MDA, 
azithromycin/Zithromax® were obtained for review.  As studies were identified for inclusion 
into the review their listed references, via abstracts, were examined for potential relevant studies.  
 
Quality assessment 
All studies meeting the initial selection criteria by reporting trachoma prevalence data pre- and 
post-program implementation and focusing specifically on the outcomes of WASH interventions 
as an added value to Mass Drug Administration (MDA) of azithromycin treatments were 
included were included. 
 
Data collection 
Specific data, including reduction of prevalence, was used to measure the effect of water, 
sanitation, and hygiene interventions for preventive chemotherapy programs on trachoma in 
relevant studies.  The data analysis was contingent on the various study methods of the published 
articles determined by an initial reading of the abstracts from all studies retrieved and narrowed 
by previously mentioned keywords.  Once titles were narrowed down, full texts were retrieved 
and relevant information was extracted onto a standardized form then pooled for summary 
estimates of the effectiveness of the interventions on the preventive chemotherapy programs 
specific to disease.  The data fields included on the extraction form are presented in Table x. 
Table X. Data Elements Extracted from Eligible Studies 
 
• Author 
• Title 
• Journal 
• Date 
• Study Type 
• Specific Intervention 
• Specific antibiotic treatment 
• Population group 
• Age Range 
• Number of Communities 
• Sample size (n) at follow up 
• Baseline prevalence 
• Post intervention prevalence 
• Effect measure 
• Estimate 
18 
 
• Year of Baseline Survey 
• Sample size (n) at baseline 
• Trachoma Grading: 
WHO, Diagnostic, or both 
• Country 
• Region 
• District 
• Year of follow up 
• 95% confidence interval 
• P-value 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter IV 
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RESULTS 
 
 
4.1 Results of the search   
The initial electronic search, conducted on September 17, 2010, generated 123 studies.  On 
October 1, 2010, an additional keyword search, including the key words SAFE strategy and 
trachoma and intervention, yielded 27 more studies.  Of the 150 abstracts retrieved, a total of 81 
were non-repeating.  All non-repeating searches were screened by one author on two different 
occasions.  After the screening, the full texts of 12 relevant articles were retrieved.  These 
articles were assessed by one author; any questions arising from the assessment of these articles 
were answered by an external source specializing in NTDs.   
 
From the 12 articles retrieved, one study (Edwards 2006) did not include antibiotic treatment due 
to limitations in distribution at the time of the study and therefore was excluded from the review.  
However, this study was followed up again two years later (Cumberland 2008) and those results 
were included in the review.  Two studies following the impact of ‘F’ and ‘E’ on antibiotics 
(Reskinoff 1995 and West 1995) were excluded because the antibiotic distributed was 
tetracycline.  As discussed previously the use of tetracycline is out-dated and compliance is 
difficult to measure.  Two other articles (Astle 2006 and Khandekar 2005) were not included 
because the antibiotic distribution was not in the capacity of a MDA to the entire community and 
was only distributed to certain individuals during trachoma prevalence screening.  Three more 
articles evaluating the comprehensive SAFE strategy turned out to be less rigorous cross-
sectional surveys (Ngondi 2006, 2008 and 2010, and Roba 2010) and were excluded because the 
assessment did not specifically look at the added value of the SAFE components to each other.  
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The remaining three studies were considered and accepted for inclusion in the review 
(Cumberland 2008, Khandekar 2005, and Lansingh 2010).  A full list of reviewed excluded 
studies is included below: 
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Table 2:  Excluded studies and reason for exclusion 
AUTHOR and 
YEAR TITLE 
REASON for 
EXCLUSION 
Astle 2006 Trachoma control in Southern Zambia--an international team project employing the SAFE strategy Spot treatment 
Edwards 2006 Impact of health education on active trachoma in hyperendemic rural communities in Ethiopia No MDA 
Khandekar 2005 Active trachoma, face washing (F) and environmental improvement (E) in a high-risk population in Oman Spot treatment 
Ngondi 2006  Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) 
strategy for trachoma control in southern Sudan: a cross-sectional study Impact Survey 
Ngondi 2008 Associations between active trachoma and community intervention with Antibiotics, Facial 
cleanliness, nd Environmental improvement (A,F,E). 
Assessed Risk 
Factors 
Ngondi 2010 Estimation of effects of community intervention with antibiotics, facial cleanliness, and 
environmental improvement (A,F,E) in five districts of Ethiopia hyperendemic for trachoma Impact Survey 
Reskinoff 1995 Health education and antibiotic therapy in trachoma control Tetracycline only 
Roba 2010 Effects of intervention with the SAFE strategy on trachoma across Ethiopia Impact Survey 
West 1995 Impact of face-washing on trachoma in Kongwa, Tanzania Tetracycline only 
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4.2  Setting and participants by article  
Including type of study, unit of randomization, place, number 
The three eligible studies were diverse in population, region, study design, and 
intervention.  The commonality was that they were all randomized control studies, with a 
specific intention to study the added value of SAFE components. 
 
Types of Participants 
Participants in these trials were residents in trachoma endemic communities, in Ethiopia, 
Vietnam, and Australia.  No age restriction was placed on the studies, however because 
active trachoma is usually diagnosed in children under 15 years of age the studies self-
limited themselves to children below the age of 15. 
 
Ethiopia: Cumberland 2008 was a randomized controlled trial (Edwards, Cumberland et 
al. 2006) with staged interventions, beginning in Guarage, Oromia, and South Welo 
districts of Ethiopia between 2002 and 2003.  A total of 1722 participants, 3- 9 years of 
age, in 37 communities were randomized into three intervention groups and one control 
group.  Five communities were used in the control group and 32 received combined 
intervention activities to serve as the intervention group.  Because 33 children with TI did 
not have follicles, the final analysis was based on a total of 1689 children. 
 
Vietnam: Khandekar 2006 was a community-based health intervention study, whereby an 
intervention community was compared to a nonintervention community, conducted in 
two communities, My Thon (MT) and Xom Ngoia (XN), in the Gia Binh district of 
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Vietnam.  In March of 2002, children aged less than15 years old in each community were 
assessed for inclusion in the study.  Participants were chosen by random selection method 
with the help of Microsoft XL software.  The total number of children assessed in the 
analysis of the study was 911. 
 
Australia: Lansingh 2010 was a prospective, case-control, community based case study 
lasting 12 months from 2000 to 2001, including two hyper-endemic Aboriginal 
Australian communities.  Both communities assessed children <15 years of age and were 
matched at baseline with regards to population age, gender, trachoma disease markers, as 
well as desert climate and environment.  Community 1 had 86 participants and 
Community 2 had 91.  After 3 months of intervention the total amount of children under 
15 years of age re-assessed was 107, after 6 months the total increased to 111 and after 12 
months the total was165. 
 
4.3  Interventions 
Including types, setting, duration 
In Cumberland 2008, populations of all villages received radio broadcasts as a hygiene 
education intervention.  In the intervention communities, all received antibiotics and one 
group received additional health information in the form of information education and 
communication materials (IEC). Themost comprehensive intervention communities 
included (in addition to MDA and IEC) drama and video.  Though all intervention 
communities received MDA, approximately half of the intervention communities 
received azithromycin 2-5 months prior to the survey and most had received more than 
one dose.    The interventions were on-going for three years. 
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In Khandekar 2006, the community of Xom Ngoia (XN) implemented the S and A 
components of the SAFE strategy. In My Thon (MT) the full SAFE strategy was 
implemented.  The additional components of the full SAFE strategy included the 
provision of clean water and sanitary latrines as well as health behavior education.   The 
specific interventions included: 
• 281 double-vault and three septic tank latrines 
• 241 bathrooms 
• 273 dug wells 
• 252 water tanks, tube wells, hand pumps 
• 202 water filters  
• 97 meetings 
• 2 marches 
• 2 performances 
• 5 billboards of trachoma-control message 
• 384 repetitions of message through village loud speaker 
The post-intervention follow up occurred in 2005, three years after the interventions 
began. 
 
In Lansingh 2010, health and facial cleanliness promotion and azithromycin were 
distributed to all members of both communities. Community 1 received an additional E 
component intervention through housing and environmental improvements.  The specific 
improvements included: 
• Road sealing- replacement of poorly built or maintained houses with 
appropriately designed houses 
• Biweekly trash collection 
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• Repair or heating/cooling systems 
• Upgrades in sewage and water lines 
• Installation of rainwater tanks 
• House yard fences bordering roads 
• Planting of trees, grass, and native plants in areas where wind and dust 
were prevalent 
• Earthworks and diversions to create micro-catchments and water ponding 
• Installation of drinking-water fountains in the school and health clinic 
 
4.4 Outcomes measures 
Including diagnosis of trachoma, WASH interventions 
In Cumberland 2008, outcome measures recorded in the study included prevalence of 
active trachoma, TF only, at baseline and then again post-intervention.  The clinical 
diagnosis of active trachoma was graded using the WHO simplified grading system.  
Signs were recorded as being present if they were seen in either or both eyes.  
Additionally, eye swabs of all children were taken to detect the presence of Polymerase 
Chain Reaction (PCR) in ocular secretions C. trachomatis deoxyribonucleic acid (DNA).   
 
Secondary outcomes measured knowledge and behavior related to trachoma control.  
These were measured through observations and questionnaires.  Observations were made 
by field workers of household facilities, cleanliness and presence of flies in and around 
the houses.  Questionnaires were delivered by a locally recruited interviewer to an adult 
care-giver in the home.  Questions included demographic details of both, respondents and 
household, they were specific to care of livestock, knowledge of health-related issues, 
practical arrangements for sanitation which was supported by observations of field 
workers of beaten paths to the latrines and human faeces in the pit. 
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In Khandekar 2006, both eyes of all family members were examined using the WHO 
trachoma grading scale, if trachoma was reported in either eye the person was considered 
to be suffering from active trachoma, TF/TI.   
 
Secondary outcomes were assessed through close-ended questionnaires, included 
measuring the knowledge, attitude and practice (KAP) regarding trachoma among 
mothers in both villages.  Questions related to attitude and practice had five grades, from 
fully agree to entirely disagree, and questions related to knowledge included: common 
symptoms of trachoma, blinding complications of trachoma, methods of prevention, of 
water sources for drinking and face washing and the advantages of a sanitary latrine.  
Evaluation of water and sanitation status was done by a water engineer who 
quantitatively and qualitatively recorded the status of the water, latrine and other 
sanitation facilities in and around the house. 
 
In Lansingh 2010, baseline measures of trachoma prevalence, facial cleanliness, and 
nasal discharge were measured.  Assessments of trachoma and facial cleanliness were 
made at 3, 6, 12 months post intervention.  Clinical assessment of trachoma was 
conducted by a single examiner using the WHO simplified grading system.  Active 
trachoma was defined as the presence of TF or TI.   
 
Secondary measures were taken by Aboriginal Health Workers (AHW) trained to assist 
with examinations, promote health education when participants visited clinics for any 
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reason, and conduct the health education campaign at the home level.  An active health 
education campaign with emphasis on facial cleanliness was instituted in schools, 
primarily facilitated by teachers and personnel from the Nganampa Health Council.  
 
Absolute facial cleanliness was defined as the absence of eye and nasal discharge.  Partial 
facial cleanliness was defined as having either eye or nasal discharge, but not both.  A 
dirty face” had eye and nasal discharge; the quality of discharge was also recorded as 
clear, abundant, or mucopurulent.  Health Living Practices (HLP) were measured by 
survey at baseline and approximately 8 months post-intervention, to be considered 
passing eight of the nine must be met.  These practices included: 
• Washing people 
• Washing clothes and bedding 
• Removing waste safely 
• Improving nutrition 
• Reducing crowding 
• Reduction negative contact between people and animals, vermin or insects 
• Reducing the negative impact of dust 
• Controlling temperature of the lining environment and 
• Reducing trauma around the house and living environment 
• Surveys were conducted house by house to assess each  
 
4.5  Effects of intervention 
Due to the heterogeneity of study design conducting a meta-analysis was not considered 
appropriate and a narrative summary of the results are presented. 
 
Primary Outcome: Prevalence of Active Trachoma 
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In Cumberland 2008, the overall prevalence (standard deviation: SD) of active trachoma 
in the 37 communities was 71.4% in 2002 and 35.6 % in 2005, illustrating around a 50% 
reduction prevalence.  The cluster summarized prevalence (SD) of active trachoma 
estimated in the control communities was 60.7% in 2002, 55.1% in 2003 and 54.5% in 
2005. The reduction in the intervention community was found statistically significant but 
the reduction in the control communities, only receiving radio as an intervention, was not 
statistically significant (P=0.692).   
 
In communities receiving azithromycin and video educational interventions, a reduction 
in the odds of active trachoma did not occur.  However, after adjustment for age, results 
suggested an almost 70% reduction in odds of active trachoma in children living in 
communities that received antibiotic treatment and IEC health education materials and 
those in communities who additionally received the video health messages.  
 
Table 3: Summary of odds of trachoma after intervention in Cumberland 2008 
Intervention Age Odds Ratio 95% CI Significance 
antibiotic treatment  
IEC health education 
video health 
All 0.93 0.42-2.07 P=.0860 
antibiotic treatment  
IEC health education 
Children 0.35 0.13-089 P=0.027 
antibiotic treatment  
IEC health education 
video health 
Children 0.31 0.11-.089 P=0.029 
 
In Khandekar 2006 study, the village with the added value of the F and E components 
experienced a decrease in the prevalence of trachoma from 13.8% at baseline to 2.3% 
post-intervention, a prevalence difference of 11.53%.  Prevalence of active trachoma 
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dropped as well in XN (SA only) from 10.2% to 5.54%, an absolute difference of 4.7%.  
The additional decline in children <15 years of age was calculated by subtracting the 
absolute decline of each village resulting in 6.8% due to the added benefit of F and E 
components in MT (SAFE). 
 
The decline of active trachoma in XN (SA) was considered to be due to the impact of the 
S and A components.  When the impact of the F and E strategy under the circumstances 
of this study was controlled for, a decline of 59.2% in active trachoma was attributed to 
the additional activities of the F and E components of the SAFE strategy in MT.   
(6.83/11.53 * 100= 59.2 %) 
 
In Lansingh 2010, a reduction in prevalence of trachoma was observed three months after 
antibiotic administration.  At that time, the active trachoma prevalence reduced from 
47.7% to 21.2% in community 1(AFE) and from 49.6% to 24.2% in community 2 (AF).  
By 12 months it rose to 30% in community 2 (AF) but remained stable at community 1 
(AFE). 
 
The reduction in trachoma prevalence between pre-intervention and 12 month post-
intervention was significant for both communities. 
X²=9.1 community 1 P=.003 
X²=8.1community 2 P= .005 
However there was no significant difference in the trachoma prevalence between the two 
communities at any examination. 
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Bellow is table 4, Trachoma Prevalence Overview, a synopsis of the results in change of 
trachoma prevalence found in the included articles. 
 
Table 4: Reported reduction of trachoma prevalence 
 
Reference           Length of Study       Baseline trachoma prevalence         Post-intervention         Percent reduction      Added Value 
 
Cumberland 2008   3 years Control  60.7%   54.5%   10% 
Overall:  71.4%   35.6%     50%    
     
Khandekar 2006     3 years  Control  10.2%   5.54%     46.1%  59.2%  
    Intervention 13.8%   2.3%     83%   
 
Lansingh 2010        1 year  Control  49.6%   30.0%       
    Intervention 47.7%   21.2%      
 
 
Secondary outcome:  
CHANGES IN KNOWLEDGE ATTITUDE AND PRACTICE 
In Cumberland 2008, there was no evidence of a difference in awareness of trachoma and 
trichiasis across intervention arms, however community summarized awareness was 
greater than 80% in all.  Since the previous surveys in 2002 and 2003, more householders 
were reported to know at least one trachoma prevention method as compared to not 
knowing any in communities receiving printed and video health education.   
 
In Khandekar 2006, the levels of KAP among the mothers of both villages at baseline and 
at the end of two years were compared.  An improvement in knowledge of the 
subcomponents of trachoma prevention among the mothers in MT (SAFE) was greater 
than among the mothers in XN (SA).  However, the attitude and practice of trachoma 
control continued to be at the same level among the mothers of both villages. 
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Lansingh 2010 did not measure KAP as a secondary outcome for trachoma knowledge; 
instead the study looked specifically at facial cleanliness in regards to a measure of the 
added benefit of the ‘E’ intervention.  Post intervention follow –up at12 months showed a 
greater percentage of clean faces and less prevalence of nasal discharge in community 2, 
the non-‘E’ intervention community.   This was due to the fact that both communities 
received interventions in hygiene education which would affect this outcome. 
Facial cleanliness: Clean faces 
• Baseline:  
▫ community 1: 30%  
▫ community 2 23% 
• Follow up (12 month):  
▫ community 1 57%  
▫ community 2 85% (x² =6.5, p=0.01) 
 
 
4.6 Quality of the evidence   
Establishing a reliable study design is crucial in providing quality evidence, yet it is 
always a challenge.  To minimize risk of bias, a study has to establish appropriate sample 
size, randomize participants, control for confounders, and select controls to match cases 
(Khandekar, Ton et al. 2006).  In this review, the study with the most comprehensive 
description of these elements was Khandekar 2006.  In Cumberland 2008 and Lansingh 
2010 it was unclear if risk of selection/sampling and confounding bias was accounted for 
or if it was simply omitted in the reporting stage.  In regards to this review, the analysis 
was conducted with information provided only from the respective articles. 
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Selection Bias: 
Of the three studies reviewed, one study, Lansingh 2010, did not mention randomizing 
participants.   Cumberland 2008 stated that the participants and communities were 
randomly chosen.  Delays with distribution prevented the study to stick to the original 
randomization schedule and local NGO’s were responsible for distribution of 
interventions on their own schedule.  The details of the original design were reported in 
the 2003 study published in 2006.  Khandekar 2006 also stated random selection.  The 
researchers also tried to minimize systematic error by having an appropriate sized 
population of all ages.  In contrast, the Lansingh 2010 study did mention that the effect 
size (which at the time had not been tested for the E component) was beyond the 
detectable level since the number of children surveyed in both communities was relative 
low.   
 
Comparability 
In Cumberland 2008, the communities used in the study were randomly selected from 
different zones within the trachoma control program areas.  There was however no 
additional information offered about the comparability of these villages.  In Khandekar 
2006 and Lansingh 2010 the studied villages were chosen specifically because of 
comparable characteristics.  In Khandekar 2008, the villages had almost similar 
population profiles and sanitation status, only the water sources differed.  In order to 
prevent cross-contamination between groups, study villages were in separate 
communities with five other villages between them and markets and educational centers 
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were also different.  In Lansingh 2010, the two communities were matched in general at 
baseline with regard to population age, gender, trachoma disease markers, as well as 
desert climate and environment, although mobility was much higher at communit1. 
 
Compliance 
Azithromycin Coverage: 
During Mass Drug Administration (MDA) 100% of the community is targeted for 
treatment as a means of preventive chemotherapy.  As in most public health initiatives 
coverage results above 80% are considered reliable in achieving intervention outcomes.  
In Cumberland 2008, 92% coverage of azithromycin distribution took place.  Lansingh 
2010, only achieved an antibiotic coverage of 73 and 55% in communities 1 and 2 
respectively, and Khandekar 2006 did not specify coverage rates on MDA that took 
place. 
Compliance of Water and Sanitation 
Compliance of the ‘F’ and ‘E’ components were measured by frequency of face washing, 
latrine use, and other sanitation interventions: 
 
In Cumberland 2008, additional householders, in intervention villages, reported family 
members used pit latrines for defecation.  As well, 60-70% of all householders in each 
arms of the study reported good rubbish disposal practices.  In intervention communities 
there was a 15% decrease of community summarized prevalence of animal faeces in the 
immediate proximity to the house. 
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In Khandekar 2006, access to a sanitary latrine and use by all members of the family 
(including children) improved in both villages in two years but it was better in MF 
(SAFE) than in XN (SA).   Additionally, fly density was significantly lower in MT 
(SAFE) than in XN (SA) at the end of two years. 
X²=270, df= 2 P= 0.00001 
Water facilities improved in both villages after two years of intervention.   However, in 
XN (SA) the quality of water and cleanliness around the water source remained 
unsatisfactory in about one-third of the houses. 
 
In Lansingh 2010, baseline prevalence of an absolutely clean face at community 1 was 
30% and 23% at community 2 while that of a dirty face was 64% and 58% respectively 
(difference not significant).  No nasal discharge occurred post-intervention in children 
less than 10 years was 30% at community 1compared to 12% in community 2. 
X²=5.7 P=0.02 
Community 1 showed positive post-intervention NHC survey results with substantial 
gains in washing clothes/bedding and removing waste safely following the intervening; 
however few houses reached the required score in most categories. 
 
Confounders 
In order to minimize misrepresentation of the overall effects of the added value of the 
WASH components, the studies controlled for confounding variables known to affect 
prevalence of trachoma.  In Khandekar 2006, the following variables were considered 
important confounders so information to determine their influence on the study was 
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collected and controlled for: age, gender, educational level, occupation, level of poverty 
and access to mass media. While active trachoma rates were projected for the study 
population, the rates by age and gender were adjusted to compensate for the differential 
representation of subgroups.  The effects of these confounders were found to be minimal 
in this study.  In both Khandekar 2006 and Lansingh 2010, climate was mentioned were 
considered a possible confounder.  It was observed that trachoma prevalence was higher 
during certain seasons.  For this reason both studies planned prevalence assessments at 
similar times and in similar conditions.  
 
Though Lansingh 2010 accounted for climate other confounders were not controlled for.  
The level of dust and flies were not assessed in community 2, and the houses were not 
surveyed before or after the intervention.  By not controlling for these confounders there 
was no valid information of the number of houses that might have passed the various 
HLP categories in community 2, and whether the A/F interventions there made any 
difference.  Cumberland made no mention of controlling for confounders in the 2008 
study design. 
 
Masking 
Khandekar 2006 was the only study to specifically mention masking as a way to 
minimize observer’s bias.  Though the study was unable to mask the field staff that 
assessed the status of the water and sanitation, the results in the houses of MT (SAFE) 
and XN (SA) were coded and given to an external evaluator.   
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Applicability 
Factors affecting generalizability of methods were different for each study and a 
summary of methodological elements are presented in Table 5.  Cumberland 2008 found 
additional value to health education yet acknowledged that educational campaigns are 
time consuming and produce variable results.  Additionally, the community mass media 
intervention used does not present an effective method of ensuring sustainable prevention 
in hyperendemic rural populations which may have limited access to mass media 
including radios.  Control for sampling bias was considered in the study design, even 
though it was reported in a previous article.  The Lansingh 2010 study however lacked 
complete applicability of evidence due to the previously mentioned absence of a reliable 
and valid study design.  The methods used in Khandekar 2006, including leveraging local 
organizations with skills of social marketing and community commitment could be 
promoted in other rural areas of developing countries as a form of trachoma control.   
 
Table 5: Methodological evaluation of the quality of included studies 
Quality of Evidence Cumberland 2008 Khandekar 2006 Lansingh 2010 
Selection Bias: 
Random Sampling 
Sample Size 
 
Yes 
N/A 
 
Yes  
Yes 
 
Yes 
No 
Comparability No Yes Yes 
Compliance:  
‘A’ Coverage  
(over 80%) 
 
Yes 
 
N/A 
 
No 
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‘F’ &’E’ Yes Yes Yes 
Confounders: 
Descriptive variables 
 
 
No 
 
Yes 
 
No 
Climate No Yes Yes 
Masking No Yes No 
Applicability Yes Yes No 
TOTAL YES: 4 8 4 
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Chapter V  
DISCUSSION AND CONCLUSION 
 
5.1 Primary outcome 
Trachoma prevalence 
All articles included in the review observed a decrease in prevalence of trachoma over the 
entire length of study.  Although the decrease occurred at different rates, the decline in 
trachoma was apparent in all villages, both control and intervention for all three studies 
reviewed in the control communities.  Where no additional interventions took place, the 
decrease was due to the natural improvements in socioeconomic status (Kuper, Solomon 
et al. 2003).  Even without intervention, change in village demographics and employment 
brought additional income resulting in access to water and sanitation facilities as well as 
increased access to mass media through additional purchasing of radio and TV.  
 
In Cumberland 2008 and Khandekar 2006, the decrease in trachoma prevalence was 
significant not only between the pre and post interventions but between the intervention 
and non-intervention communities. This suggests that adding water, sanitation, and 
hygiene education interventions to the ongoing mass antibiotic distribution had a 
significant impact on reducing the prevalence of trachoma.  In contrast however, 
Lansingh 2010 found a significant decline between pre and post intervention but not 
between villages.  The study was unable to determine if the ‘E’ environmental component 
added significant value to the SAFE strategy between the two villages studied.  There are 
many reasons for the variability in results between the three studies including quality of 
study design and coverage rates of antibiotic.  
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In Cumberland 2008, the decline in prevalence was attributed to treatment of 
azithromycin; however, the other components studied as well reported added value to the 
decline of trachoma prevalence, around a 50% decrease from baseline to post-
intervention follow up.  The study suggested that health education and community based 
programs appeared to have additional positive results on the ‘AFE’ components of SAFE, 
but percentage prevalence decrease as a result of the AFE components was not separately 
calculated.  Khandekar 2006, did calculate the added benefit and found providing the ‘F’ 
and ‘E’ components in addition to the ‘S’ and ‘A’ contributed to a nearly 60% decline in 
active trachoma prevalence.  These components were additionally responsible for the 
decline of more than one-third of the active trachoma prevalence in children, confirming 
the association of water and sanitation improvement with the decline of active trachoma. 
 
In the Lansingh 2010 case study, the ‘A’ and ‘F’ components of the SAFE strategy 
interventions significantly reduced the prevalence of trachoma in both communities 1 and 
2.  Though both communities achieved significant reductions in trachoma prevalence 
between pre-intervention and 12 month post-intervention assessments, there was no 
evidence that the specific environmental changes implemented in community 1 had any 
additional impact to the improvement of facial cleanliness and antibiotic distribution.  
The reason for the lack of significant change was due to the small sample size, low 
antibiotic coverage, and problems with the overall study design.   
   
5.3 Secondary outcome 
Knowledge, Practice, Attitude (KPA) 
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Changing deep-rooted cultural behaviors is difficult; however if effective it creates a 
collective and sustainable awareness.  In Cumberland 2008, the percentage of 
householders surveyed who knew about trachoma was 45%; of those only 20% knew 
about trachoma risk factors and treatment options.  Previously, the emphasis for 
prevention and treatment methods for trachoma focused on traditional beliefs and 
practices.  It was reported that in 2003 and 2005, a shift occurred away from traditional 
beliefs to a better understanding of trachoma and the SAFE strategy as a preventative 
method and cure.  Even with these changes, the knowledge and good practices surveyed 
remained around 40% on average since baseline and percentages of reported correct 
treatment methods remained low in all districts surveyed post intervention.   
 
In the Khandekar 2006 study, a notable improvement in the KAP of mothers after two 
years was demonstrated.  The reason for the improvement was due to the leveraging of 
organizations within the village in addition to passive advocacy through mass media.  
The model included using women’s associations and involving school teachers to educate 
the community.  Lansingh 2010, did not measure KAP as an outcome of the added 
benefit of the ‘E’ component. 
 
Facial Cleanliness and nasal discharge: 
In Lansingh 2010, contrary to the assumed outcome, community 2 which received on the 
‘A’ and ‘F’ components of SAFE performed better than community 1, which had the 
additional ‘E’ component, in regards to facial cleanliness and nasal discharge.  These 
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secondary outcomes however were not easily correlated to the small difference in 
prevalence of trachoma. 
 
5.4 Authors Conclusions 
Implication for practice 
In order to eliminate blinding trachoma as a public health problem, recurrence of the 
active form of the disease must be interrupted before repeated scarring leads to trichiasis.  
The antibiotic component of the SAFE strategy is a quick fix to the immediate problem.  
The ‘F’ and ‘E’ components are the more sustainable interventions, yet little research has 
been done on the actual amount of added value the individual ‘A’‘F’&’E’ components 
have to one another.  After thorough review of the articles, articles were found which 
documented the ‘F’ and ‘E’ components provide significant value to the overall decrease 
of prevalence of active.  However, the limited results of the search suggest more research 
can better elucidate the ability of the “F” and “E” components to reduce trachoma 
prevalence and ultimately impact blinding. 
 
Recommendations for research 
Because several impact studies are taking place to leverage for donation of Pfizer donated 
Zithromax® by ITI, researchers can continue to study the impact of the added value of 
the ‘A’‘F’&’E’ components by establishing more rigorous study designs at baseline.  
This would include making sure to have a randomized selection process, applying 
specific interventions, and controlling for confounding variable.  Additionally, with the 
information already provided a review of the overall impact of the SAFE strategy would 
be beneficial in advocating for more collaborative efforts between sectors.
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Perhaps these summaries of studies are better placed in an appendix. 
Table 6: Summary of included studies and health measures       
PAPER INTERVENTION COUNTRY 
and 
POPULATION 
STUDY 
QUALITY 
HEALTH 
OUTCOME 
AGE 
GROUP 
MEASURE STATISTICAL 
TEST 
Good Trachoma 3-9 years 
   
Change in 
Prevalence 
    
 
Cumberland 2008 Control: only radio 
MDA and radio  
MDA, radio and information education 
and communication materials (IEC) 
MDA, IEC, and community video and 
drama 
Ethiopia 
1689 
    
 
OR 0.35 radio, 
MDA, IEC  
CI 0.13-0.89  
P Value:  
0.027  
OR 0.31 radio, 
MDA, IEC, and 
video  
CI 0.022-.89  
P Value:  
0.029  
 
Khandekar 2006 Water Supply 
Sanitation Supply 
Vietnam 
911 
Great Trachoma < 15 Change in 
Prevalence 
 
Lansingh 2010 Environmental Enhancements 
Water Supply 
 
 
Australia 
111 
Poor Trachoma < 15 Change in 
Prevalence 
 
 
 
X²=9.1  
community 1  
P Value:0.003  
X²=8.1  
community 2  
P Value:0.005 
OR 0.99 
CI 0.93-1.05  
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Cumberland, P., T. Edwards, et al. (2008). "The impact of community level treatment and preventative interventions on trachoma 
prevalence in rural Ethiopia." Int J Epidemiol  
Type of trial: randomized control study 
Allocation: staged cluster intervention 
Methods 
Unit of randomization: community staged cluster intervention 
Country: Ethiopia 
Districts: 
• Gurage 
• Oromia 
• South Welo 
 
Communities: 40 originally 
 
The final survey included 5 control villages and 32 intervention 
Baseline Year: 2002          
Number (n): 1958 
Age: 3-9 
Clinical Grading: WHO  
Lab tests: Yes 
Inclusion criteria: Active trachoma: TF 
Participants 
Baseline 
Prevalence: 71.4% 
Control: only radio 
MDA and radio  
MDA, radio and information education and communication materials (IEC) 
Interventions 
MDA, IEC, and community video and drama 
Country: Ethiopia 
Districts: 
Gurage 
Oromia 
South Welo 
Communities: 40 (5 control and 32 intervention) 
Year: 2005 
Number (n):  1689 
Age:3-9 
Communities: 37 of the original 40 (3 were found  
Clinical Grading 
Lab tests 
Inclusion criteria: Active trachoma: TF 
Participants 
Post-intervention 
Prevalence: 34.0% 
OR 0.35 radio, MDA, IEC 
CI 95%: 0.13-0.89 
P Value: 0.027 
OR 0.31 radio, MDA, IEC, and video 
CI 95%: 0.022-.89 
Effect Measure 
P Value: 0.029 
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Khandekar, R., T. K. Ton, et al. (2006). "Impact of face washing and environmental improvement on reduction of active trachoma 
in Vietnam-a public health intervention study." Ophthalmic Epidemiol  
Type of trial: health intervention study 
Allocation: unmatched 1:1 
Methods 
Unit of randomization: community  
Country: Vietnam 
Districts: 
MT 
XN 
Communities: 2 
Year: 2002 
Number (n):  
MT: 447 
XN:463 
Age: <15 
Clinical Grading: WHO  
Inclusion criteria: Active trachoma: TF/ TI 
Participants 
Baseline 
Prevalence:  
MT: 13.8% 
XN:10.2% 
281 double-vault and three septic tank latrines 
241 bathrooms 
273 dug wells 
252 water tanks 
tube well 
hand pump 
97 meetings 
2 marches 
2 performances 
5 billboards 
Interventions 
384 times through village loud speaker 
Country: Vietnam 
 
Districts: 
MT 
XN 
Communities: 2 
Year: 2005 
Number (n):   
MT: 482 
XN:429 
Age: 
Age: <15 
Clinical Grading: WHO  
Inclusion criteria: Active trachoma: TF/TI 
Participants 
Post-intervention 
Prevalence:  
MT: 2.3% 
XN:5.5% 
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Lansingh, V. C., B. N. Mukesh, et al. (2010). "Trachoma control in two Central Australian Aboriginal communities: a case study." 
Int Ophthalmol 
Type of trial: prospective case study 
Allocation:  
Methods 
Unit of randomization: community  
Country: Australia 
Communities: 2 
Year: 1999 through August 2000 
Number (n):  
Community 1: 86 
Community 2:91 
Age: < 15 
Clinical Grading: WHO  
Inclusion criteria: Active trachoma: TF/ TI 
Participants 
Baseline 
Prevalence:  
Community 1: 48% 
Community 2: 50% 
• Road sealing- replacement of poorly built or maintained houses with appropriately 
designed houses 
• Biweekly trash collection 
• Repair or heating/cooling systems 
• Upgrades in sewage and water lines 
• Installation of rainwater tanks 
• House yard fences bordering roads 
• Planting of trees, grass, and native plants in areas where wind and dust were prevalent 
• Earthworks and diversions to create micro-catchments and water ponding 
Interventions 
• Installation of drinking-water fountains in the school and health clinic 
Country: Australia 
Communities: 2 
Year: 2001 
Number (n): 3 month 6 month 12 month 
Community 1: 35 41 79 
Community 2: 72 70 86 
Age:<15 
Communities: 2 
Clinical Grading:WHO 
Inclusion criteria: Active trachoma: TF/TI 
Prevalence: 
 
Community 1 Community 2 
3 month:  21.2% 24.2% 
6 month   
Participants 
Post-intervention 
12 month  30% 
X²=9.1 community 1 
P Value: .003 
Effect Measure 
X²=8.1community 2 
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